PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: NWR Virtual Healthcare Conference Presentation, page-54

  1. 43 Posts.
    lightbulb Created with Sketch. 11
    Proper research is exactly the key. Day 56 data suggests you're incorrect, let's look at the 6mo data shortly. The amount of people posting on HC is hardly research.
    I suggest you look at the research on OA prevalence, hardly up rampers estimates!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.